Attorneys, Insurers Disagree With Manufacturers On Need For Clinical Evidence For MCIT Coverage
CMS says in its MCIT proposal that there’s no obligation for clinical studies, but AHIP is concerned about “clinical appropriateness” of devices
Both insurance group AHIP and the MedPAC group of Medicare advisors are insisting on CMS reimbursement for medical devices only supported by clinical trials. Industry attorneys weigh in.
